Found 4 matching trials
Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia
N/AThis is an open-label, expanded access study of exebacase used in addition ...
Status
No Longer Available
Location
CF-301-107 Study Site
Direct Lysis of Staph Aureus Resistant Pathogen Trial of Exebacase
PHASE3The purpose of this superiority study is to evaluate the efficacy and safet...
Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia
PHASE2The purpose of this study is to evaluate the safety, tolerability, efficacy...
Location
CF-301-102 Study Site
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
PHASE1A Phase 1, Placebo-Controlled, Dose-Escalating Study to Examine the Safety ...
Location
Multiple Locations